Lantern Pharma Inc. (LTRN)
$0.74-8.64%Close
SELLCRISIS · day 43
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $9M
- Beta
- 2.32
- P/E (TTM)
- -0.59
- Short % float
- 5.06%
- Days to cover
- 1.3
- SI change
- -12.9%
- 1W
- -21.28%
- 1M
- -56.73%
- vs SPY 1W
- -21.70%
- vs SPY 1M
- -58.79%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on LTRN?
- LOPJLB’s latest quantitative signal on Lantern Pharma Inc. (LTRN) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is LTRN in?
- Lantern Pharma Inc. (LTRN) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Lantern Pharma Inc. (LTRN) do?
- Lantern Pharma Inc. is a clinical-stage biotechnology firm dedicated to revolutionizing drug development through the strategic application of artificial intelligence, machine learning, and comprehensive genomic data analysis. Their primary drug candidate, LP-100, is currently undergoing Phase II clinical trials, targeting metastatic, castration-resistant prostate cancer. The company is also adv…